![]() ![]() ![]() ![]() Įvolutionary analyses of joint kinematics and muscle mechanics suggest that, during cyclic behaviors, tetrapod feeding systems are optimized for precise application of forces over small displacements during chewing while locomotor systems are more optimized for large and rapid joint excursions during walking and running. We pre-registered our meta-analysis, with all search protocol, datasets, code, and supplementary made available on the OSF. Study heterogeneity was, Q(XX) = XXX.XX, p =. We found support/no support/mixed support for action-effect in ], support/no support/mixed support for action-effect in ], and support/no support/mixed support for action-effect in ]. In this registered report, we conducted a meta-analysis of the action effect literature (k =, N =, 1982-2021). This meta-analysis confirms the superiority of combination therapy over monotherapy in rheumatoid arthritis, in accordance to the usual guidelines.Īction-effect refers to the phenomenon in which people experience, associate, or attribute stronger emotions for action compared to inaction. The results were mostly similar for all other outcomes without increasing the risk of adverse effects. Compared to bDMARD monotherapy, combination therapy gives a better ACR 20 at 24 weeks (RR: 0.88 (0.84-0.94)) in fixed and random effect models, and this result is sustained at 52 and 104 weeks. No study satisfied our search criteria for anakinra, certolizumab and infliximab. Major outcome: ACR 20 response criteria at 24 weeks.Ĭlinical and radiographic criteria at week 24, 52 and 104.Ģ3 trials (6358 patients), including seven bDMARDs and one other molecule: Anbainuo (anti-TNF-R). Research was limited to randomized controlled trials. Various zoom types are supported (mouse wheel, pinch, selection).įull Disclosure: I have been heavily involved in development of Visiblox, hence I know that library in much more detail than the others.Update the available evidence comparing biologic disease-modifying antirheumatic drugs (bDMARDs) in combination with conventional synthetic disease-modifying antirheumatic drugs (CsDMARDs) to bDMARDs in monotherapy in patients with rheumatoid arthritis. Supports many 2D series types and provides the interactive zooming feature that supports the touch mode. Supports most common 2D Series types, zooming and panning (scrolling) operations can be performed using the mouse, keyboard, and touch gestures. Supports lots of 2D charts and zooming without animation, might need to do some extra work for smoother zooming.(This service is no longer available) Supports lots of 2D charts, has some support for zooming and panning, you might need to do a little work on that. See this blog article on how to use zooming. Supports most important 2D charts, zooming and panning. ( See this blog post on using zooming / panning across multiple charts) Supports DirectX accelerated 2D & 3D charts, comes with zooming and panning, mouse-wheel with animation on zoom. Paid tools with built in pan / zoom support: Supports stacked charts, equivalent to the Silverlight version. Supports most important 2D charts, you'll have to implement pan / zoom yourself. Unfortunately it's not been updated since April 30, 2009.įree tools without built in pan / zoom support: DynamicDataDisplay - a nice, open source data visualization library. ![]()
0 Comments
Leave a Reply. |